AI trains doctors to better detect stomach cancer risk
NCT ID NCT07208864
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an artificial intelligence (AI) system can help doctors more accurately score a stomach condition called gastric intestinal metaplasia, which can lead to cancer. Eight endoscopists will review videos of stomach exams, some with AI help and some without, to see if the AI improves their scoring. The goal is to make diagnosis more consistent and reliable, especially for less experienced doctors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-assisted EGGIM scoring system
What this could lead to
If it works, this could lead to more accurate and consistent diagnosis of a precancerous stomach condition, helping doctors identify high-risk patients earlier.
What could go wrong
This is a very small, early study with only 8 endoscopists, so results may not apply broadly. The AI is a training tool, not a treatment, and its real-world impact remains uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC INTESTINAL METAPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China